NXGN — Nextgen Healthcare Cashflow Statement

0.000.00%

Last trade - 00:00

TechnologyBalancedMid Cap

Annual cashflow statement for Nextgen Healthcare, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	24.5	7.5	9.52	1.62	-2.65
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items	23.3	43.5	38.3	39.4	32.5
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-40.7	-7.8	10.3	-30	-13.8
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities	50.5	85.6	98.5	53.5	43.7
Capital Expenditures	-25.5	-26.9	-28.3	-28.1	-37.3
Purchase of Fixed Assets
Software Development Costs
Other Investing Cash Flow Items	0	-69.2	-0.206	0	-180
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-25.5	-96.1	-28.5	-28.1	-217
Financing Cash Flow Items	-3.18	-4.14	-6.2	-6.43	-19.3
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-21.6	116	-132	-37.3	213
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	3.3	106	-61.7	-11.8	39.2